Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival.
Saved in:
| Title: | Bevacizumab and Paclitaxel in Advanced, Hormone Receptor-Positive Breast Cancer: Multifactor Dimensionality Reduction Methodology to Identify Best Overall Survival. |
|---|---|
| Authors: | Coltelli L; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Pontedera Hospital, Azienda USL Toscana Nord Ovest, Pontedera, Italy., Orlandi P; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Finale C; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Musettini G; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Masini LC; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Scalese M; Institute of Clinical Physiology, Italian National Research Council-CNR, Pisa, Italy., Soria G; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Sartori E; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Nodari Y; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Arrighi G; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Pontedera Hospital, Azienda USL Toscana Nord Ovest, Pontedera, Italy., Bandini A; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Banchi M; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Tacchi C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Tang D; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Salvadori B; Division of Medical Oncology II, Azienda Ospedaliero-Universitaria Pisana, S. Chiara Hospital, Pisa, Italy., Tanganelli L; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Versilia Hospital, Azienda Usl Toscana Nord Ovest, Lido di Camaiore, Italy., Giovannelli S; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, San Luca Hospital, Azienda Usl Toscana Nord Ovest, Lucca, Italy., Pistelli M; Division of Medical Oncology, Umberto I Salesi-Lancisi Hospital, Azienda Ospedaliero-Universitaria Umberto I, Ancona, Italy., Cupini S; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Lucchesi M; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Apuane Hospital, Azienda Usl Toscana Nord Ovest, Massa e Carrara, Italy., Cosimi A; SC Screening, Azienda USL Toscana Sud Est, Siena, Italy., Lorenzini G; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Versilia Hospital, Azienda Usl Toscana Nord Ovest, Lido di Camaiore, Italy., Biasco E; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Caparello C; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Acconci G; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology II, Azienda Ospedaliero-Universitaria Pisana, S. Chiara Hospital, Pisa, Italy., Fontana E; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Bona E; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Farnesi A; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Pellino A; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Marini A; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., De Maio E; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Stasi I; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Barbara C; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Sammarco E; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Rosada J; Department of Internal Medicine, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Internal Medicine, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Allegrini G; Department of Oncology, Azienda USL Toscana Nord Ovest, Livorno, Italy.; Division of Medical Oncology, Livorno Hospital, Azienda USL Toscana Nord Ovest, Livorno, Italy., Bocci G; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. |
| Source: | Oncology research [Oncol Res] 2026 Apr 22; Vol. 34 (5), pp. 13. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1555-3906 |
|---|---|
| DOI: | 10.32604/or.2026.073799 |
